Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G DuPont

Showing results (201-210 of 242) with videos related to

Pageof 25
Sort By:
Journal Francais D'Ophtalmologie|December 25, 2008
[Vitreoretinal outpatient surgery: clinical and financial considerations]C Creuzot-Garcher, H Aubé, F Candé, et al.
European Review for Medical and Pharmacological Sciences|June 17, 2024
Improving management of intravenous maintenance fluids in the emergency department of a university hospitalS C M Wuyts, S Scheyltjens, M Vandendriessche, et al.
British Journal of Clinical Pharmacology|November 2, 2022
Added value of patient- and drug-related factors to stratify drug-drug interaction alerts for risk of QT prolongation: Development and validation of a risk prediction modelKatoo M Muylle, Sven van Laere, Luigi Pannone, et al.
American Journal of Therapeutics|March 31, 1999
Nebivolol versus nifedipine in the treatment of essential hypertension: a double-blind, randomized, comparative trialL Van Nueten, Y Lacourcière, G Vyssoulis, et al.
Journal of Perinatal Medicine|August 2, 2011
Determinants of folic acid use in a multi-ethnic population of pregnant women: a cross-sectional studyMohamed A Baraka, Stephane Steurbaut, Liesbeth Leemans, et al.
Journal of Hypertension|April 10, 2008
Brain and peripheral angiotensin II type 1 receptors mediate renal vasoconstrictor and blood pressure responses to angiotensin IV in the ratRui Yang, Ilse Smolders, Dimitri De Bundel, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 10, 1998
Physiological red blood cell kinetic model to explain the apparent discrepancy between adenosine breakdown inhibition and nucleoside transporter occupancy of draflazineE Snoeck, K Ver Donck, P Jacqmin, et al.
British Journal of Pharmacology|August 1, 1991
Identification of a D1 dopamine receptor, not linked to adenylate cyclase, on lactotroph cellsD F Schoors, G P Vauquelin, H De Vos, et al.
Cardiovascular Drugs and Therapy|August 1, 1991
Twenty-four hour ambulatory blood pressure profile of a new slow-release formulation of diltiazem in mild to moderate hypertensionA G Dupont, J M Coupez, P Jensen, et al.
Journal of Hypertension|November 13, 2009
Renal vasoconstrictor and pressor responses to angiotensin IV in mice are AT1a-receptor mediatedRui Yang, Thomas Walther, Florian Gembardt, et al.
Pageof 25

Showing results (201-210 of 242) with videos related to

Sort By:
Pageof 25
Journal Francais D'Ophtalmologie|December 25, 2008
[Vitreoretinal outpatient surgery: clinical and financial considerations]C Creuzot-Garcher, H Aubé, F Candé, et al.
European Review for Medical and Pharmacological Sciences|June 17, 2024
Improving management of intravenous maintenance fluids in the emergency department of a university hospitalS C M Wuyts, S Scheyltjens, M Vandendriessche, et al.
British Journal of Clinical Pharmacology|November 2, 2022
Added value of patient- and drug-related factors to stratify drug-drug interaction alerts for risk of QT prolongation: Development and validation of a risk prediction modelKatoo M Muylle, Sven van Laere, Luigi Pannone, et al.
American Journal of Therapeutics|March 31, 1999
Nebivolol versus nifedipine in the treatment of essential hypertension: a double-blind, randomized, comparative trialL Van Nueten, Y Lacourcière, G Vyssoulis, et al.
Journal of Perinatal Medicine|August 2, 2011
Determinants of folic acid use in a multi-ethnic population of pregnant women: a cross-sectional studyMohamed A Baraka, Stephane Steurbaut, Liesbeth Leemans, et al.
Journal of Hypertension|April 10, 2008
Brain and peripheral angiotensin II type 1 receptors mediate renal vasoconstrictor and blood pressure responses to angiotensin IV in the ratRui Yang, Ilse Smolders, Dimitri De Bundel, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 10, 1998
Physiological red blood cell kinetic model to explain the apparent discrepancy between adenosine breakdown inhibition and nucleoside transporter occupancy of draflazineE Snoeck, K Ver Donck, P Jacqmin, et al.
British Journal of Pharmacology|August 1, 1991
Identification of a D1 dopamine receptor, not linked to adenylate cyclase, on lactotroph cellsD F Schoors, G P Vauquelin, H De Vos, et al.
Cardiovascular Drugs and Therapy|August 1, 1991
Twenty-four hour ambulatory blood pressure profile of a new slow-release formulation of diltiazem in mild to moderate hypertensionA G Dupont, J M Coupez, P Jensen, et al.
Journal of Hypertension|November 13, 2009
Renal vasoconstrictor and pressor responses to angiotensin IV in mice are AT1a-receptor mediatedRui Yang, Thomas Walther, Florian Gembardt, et al.
Pageof 25